Paeonol reduces microbial metabolite α-hydroxyisobutyric acid to alleviate the ROS/TXNIP/NLRP3 pathway-mediated endothelial inflammation in atherosclerosis mice.

MLA

Liu, Yarong, et al. “Paeonol Reduces Microbial Metabolite α-Hydroxyisobutyric Acid to Alleviate the ROS/TXNIP/NLRP3 Pathway-Mediated Endothelial Inflammation in Atherosclerosis Mice.” Chinese Journal of Natural Medicines, vol. 21, no. 10, Oct. 2023, pp. 759–74. EBSCOhost, https://doi.org/10.1016/S1875-5364(23)60506-0.

APA

Liu, Y., Wu, H., Wang, T., Shi, X., He, H., Huang, H., Yang, Y., & Dai, M. (2023). Paeonol reduces microbial metabolite α-hydroxyisobutyric acid to alleviate the ROS/TXNIP/NLRP3 pathway-mediated endothelial inflammation in atherosclerosis mice. Chinese Journal of Natural Medicines, 21(10), 759–774. https://doi.org/10.1016/S1875-5364(23)60506-0

Chicago

Liu, Yarong, Hongfei Wu, Tian Wang, Xiaoyan Shi, Hai He, Hanwen Huang, Yulong Yang, and Min Dai. 2023. “Paeonol Reduces Microbial Metabolite α-Hydroxyisobutyric Acid to Alleviate the ROS/TXNIP/NLRP3 Pathway-Mediated Endothelial Inflammation in Atherosclerosis Mice.” Chinese Journal of Natural Medicines 21 (10): 759–74. doi:10.1016/S1875-5364(23)60506-0.